World journal of urology · 2016
Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting.
Сравнительное исследованиеСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Long Jean-Alexandre, Bernhard Jean-Christophe, Bigot Pierre, Lanchon Cecilia, Paparel Philippe, Rioux-Leclercq Nathalie, Albiges Laurence, Bodin Thomas, Nouhaud François-Xavier, Boissier Romain, Gimel Pierre, Méjean Arnaud, Masson-Lecomte Alexandra, Grenier Nicolas, Cornelis Francois, Grassano Yohann, Comat Vincent, Le Clerc Quentin Come, Rigaud Jérome, Salomon Laurent, Descotes Jean-Luc, Sengel Christian, Roupret Morgan, Verhoest Gregory, Ouzaid Idir, Arnoux Valentin, Bensalah Karim, French association of Urology Cancerology Comitee (CCAFU)
Аннотация
PURPOSE: To compare partial nephrectomy (PN) and percutaneous ablative therapy (AT) for renal tumor in imperative indication of nephron-sparing technique (NST).
MATERIALS AND METHODS: Between 2000 and 2015, 284 consecutive patients with a kidney tumor in an imperative indication of NST were retrospectively included in a multicenter study. PN [open (n = 146), laparoscopic (n = 9), or robotic approach (n = 17)] and AT [radiofrequency ablation (n = 104) or cryoablation (n = 8)] were performed for solitary kidney (n = 146), bilateral tumor (n = 78), or chronic kidney disease (CKD) (n = 60).
RESULTS: Patients in the PN group had larger tumors and a higher RENAL score. There were no differences between the two groups with respect to age, reasons for imperative indication, and preoperative eGFR. Patients in the AT group had a higher ASA and CCI. PN had worse outcomes than AT in terms of transfusion rate, length of stay, and complication rate. Local radiological recurrence-free survival was better for PN, but metastatic recurrence was similar. Percentage of eGFR decrease was similar in the two groups. Temporary or permanent dialysis was not significantly different. On multivariate analysis, PN and AT had a similar eGFR change when adjusted for tumor complexity, reason of imperative indication and CCI.
CONCLUSION: In imperative indication of nephron-sparing treatment for a kidney tumor, either PN or AT can be proposed. PN offers the ability to manage larger and more complex tumors while providing a better local control and a similar renal function loss.
MATERIALS AND METHODS: Between 2000 and 2015, 284 consecutive patients with a kidney tumor in an imperative indication of NST were retrospectively included in a multicenter study. PN [open (n = 146), laparoscopic (n = 9), or robotic approach (n = 17)] and AT [radiofrequency ablation (n = 104) or cryoablation (n = 8)] were performed for solitary kidney (n = 146), bilateral tumor (n = 78), or chronic kidney disease (CKD) (n = 60).
RESULTS: Patients in the PN group had larger tumors and a higher RENAL score. There were no differences between the two groups with respect to age, reasons for imperative indication, and preoperative eGFR. Patients in the AT group had a higher ASA and CCI. PN had worse outcomes than AT in terms of transfusion rate, length of stay, and complication rate. Local radiological recurrence-free survival was better for PN, but metastatic recurrence was similar. Percentage of eGFR decrease was similar in the two groups. Temporary or permanent dialysis was not significantly different. On multivariate analysis, PN and AT had a similar eGFR change when adjusted for tumor complexity, reason of imperative indication and CCI.
CONCLUSION: In imperative indication of nephron-sparing treatment for a kidney tumor, either PN or AT can be proposed. PN offers the ability to manage larger and more complex tumors while providing a better local control and a similar renal function loss.
Предметные рубрики MeSH
Ablation TechniquesAgedBlood TransfusionCarcinoma, Renal CellCatheter AblationComorbidityCongenital AbnormalitiesCryosurgeryDisease-Free SurvivalFemaleGlomerular Filtration RateHumansKidneyKidney DiseasesKidney NeoplasmsLaparoscopyLength of StayMaleMiddle AgedMultivariate AnalysisNeoplasms, Multiple PrimaryNephrectomyNephronsOrgan Sparing TreatmentsPostoperative ComplicationsRenal Insufficiency, ChronicRetrospective StudiesRobotic Surgical ProceduresTreatment OutcomeTumor Burden